178 related articles for article (PubMed ID: 15876464)
21. Primary tumor volume of nasopharyngeal carcinoma: prognostic significance for local control.
Sze WM; Lee AW; Yau TK; Yeung RM; Lau KY; Leung SK; Hung AW; Lee MC; Chappell R; Chan K
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):21-7. PubMed ID: 15093895
[TBL] [Abstract][Full Text] [Related]
22. [Intensity modulated radiation therapy for 49 patients with recurrent nasopharyngeal carcinoma].
Lu TX; Zhao C; Han F; Huang Y; Deng XW; Lu LX; Zeng ZF; Huang SM; Lin CG; Cui NJ
Zhonghua Zhong Liu Za Zhi; 2003 Jul; 25(4):386-9. PubMed ID: 12921573
[TBL] [Abstract][Full Text] [Related]
23. Prospective phase II trial of concomitant boost radiotherapy for stage II nasopharyngeal carcinoma.
Lu JJ; Kong L; Shakespeare TP; Loh KS; Zhang Q; Tan KS; Lee KM
Oral Oncol; 2008 Jul; 44(7):703-9. PubMed ID: 18061528
[TBL] [Abstract][Full Text] [Related]
24. [Dosimetric analysis of radiotherapy with middle shielding blocks of different widths at the lower cervical supraclavicular field for stage N2-3 nasopharyngeal carcinoma].
Li FM; Luo W; He ZC; Zhang L; Sun Y; Qin WJ; Lu LX; Han F; Liu XQ; Liu MZ
Ai Zheng; 2007 Oct; 26(10):1127-32. PubMed ID: 17927886
[TBL] [Abstract][Full Text] [Related]
25. [Simultaneous modulated accelerated radiation therapy in the treatment of nasopharyngeal cancer].
Xie CY; Wu SX; Jin XC; Yu JY; Wang JH; Li WF; Zhang P
Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(34):2412-5. PubMed ID: 18036320
[TBL] [Abstract][Full Text] [Related]
26. [Repeated radiotherapy in locally recurrent nasopharyngeal cancer].
Lengyel E; Baricza K; Somogyi A; Olajos J; Pápai Z; Gödény M; Németh G; Esik O
Orv Hetil; 2002 Oct; 143(41):2343-50. PubMed ID: 12434736
[TBL] [Abstract][Full Text] [Related]
27. [A matched cohort analysis of three-dimensional conformal radiotherapy versus conventional radiotherapy for primary nasopharyngeal carcinoma].
Liu XQ; Luo W; Tang YQ; He ZC; Sun Y; Ma J; Lu TX; Liu MZ
Ai Zheng; 2008 Jun; 27(6):606-11. PubMed ID: 18570734
[TBL] [Abstract][Full Text] [Related]
28. A Phase II study of synchronous three-dimensional conformal boost to the gross tumor volume for patients with unresectable Stage III non-small-cell lung cancer: results of Korean Radiation Oncology Group 0301 study.
Cho KH; Ahn SJ; Pyo HR; Kim KS; Kim YC; Moon SH; Han JY; Kim HT; Koom WS; Lee JS
Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1397-404. PubMed ID: 19117690
[TBL] [Abstract][Full Text] [Related]
29. Stereotactic radiosurgery plus intracavitary irradiation in the salvage of nasopharyngeal carcinoma.
Low JS; Chua ET; Gao F; Wee JT
Head Neck; 2006 Apr; 28(4):321-9. PubMed ID: 16287135
[TBL] [Abstract][Full Text] [Related]
30. Prognostic impact of primary tumor volume in patients with nasopharyngeal carcinoma treated by definitive radiation therapy.
Shen C; Lu JJ; Gu Y; Zhu G; Hu C; He S
Laryngoscope; 2008 Jul; 118(7):1206-10. PubMed ID: 18418278
[TBL] [Abstract][Full Text] [Related]
31. Importance of protocol target definition on the ability to spare normal tissue: an IMRT and 3D-CRT planning comparison for intraorbital tumors.
Hein PA; Gladstone DJ; Bellerive MR; Hug EB
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1540-8. PubMed ID: 16029816
[TBL] [Abstract][Full Text] [Related]
32. Three-dimensional conformal radiotherapy for locally advanced (Stage II and worse) head-and-neck cancer: dosimetric and clinical evaluation.
Portaluri M; Fucilli FI; Castagna R; Bambace S; Pili G; Tramacere F; Russo D; Francavilla MC
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):1036-43. PubMed ID: 16750321
[TBL] [Abstract][Full Text] [Related]
33. Effectiveness of three-dimensional conformal radiotherapy for treating early primary nasopharyngeal carcinoma.
Luo W; Ye L; Yu Z; He Z; Li F; Liu M
Am J Clin Oncol; 2010 Dec; 33(6):604-8. PubMed ID: 20051809
[TBL] [Abstract][Full Text] [Related]
34. Primary tumor volume of nasopharyngeal carcinoma: prognostic significance for recurrence and survival rate.
Chu ST; Wu PH; Chou P; Lee CC
Eur Arch Otorhinolaryngol; 2008 Jul; 265 Suppl 1():S115-20. PubMed ID: 18236065
[TBL] [Abstract][Full Text] [Related]
35. A split-organ delineation approach for dose optimisation for intensity-modulated radiotherapy for advanced T-stage nasopharyngeal carcinoma.
Chau RM; Leung SF; Kam MK; Cheung KY; Kwan WH; Yu KH; Chiu SK; Chan AT
Clin Oncol (R Coll Radiol); 2008 Mar; 20(2):134-41. PubMed ID: 18031999
[TBL] [Abstract][Full Text] [Related]
36. Persistently better treatment planning results of intensity-modulated (IMRT) over conformal radiotherapy (3D-CRT) in prostate cancer patients with significant variation of clinical target volume and/or organs-at-risk.
Fenoglietto P; Laliberte B; Allaw A; Ailleres N; Idri K; Hay MH; Moscardo CL; Gourgou S; Dubois JB; Azria D
Radiother Oncol; 2008 Jul; 88(1):77-87. PubMed ID: 18215434
[TBL] [Abstract][Full Text] [Related]
37. Outcome of fractionated stereotactic radiotherapy for 90 patients with locally persistent and recurrent nasopharyngeal carcinoma.
Wu SX; Chua DT; Deng ML; Zhao C; Li FY; Sham JS; Wang HY; Bao Y; Gao YH; Zeng ZF
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):761-9. PubMed ID: 17601682
[TBL] [Abstract][Full Text] [Related]
38. Quality of life and survival outcome for patients with nasopharyngeal carcinoma receiving three-dimensional conformal radiotherapy vs. intensity-modulated radiotherapy-a longitudinal study.
Fang FM; Chien CY; Tsai WL; Chen HC; Hsu HC; Lui CC; Huang TL; Huang HY
Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):356-64. PubMed ID: 18355980
[TBL] [Abstract][Full Text] [Related]
39. Radiotherapy for nasopharyngeal carcinoma--transition from two-dimensional to three-dimensional methods.
Teo PM; Ma BB; Chan AT
Radiother Oncol; 2004 Nov; 73(2):163-72. PubMed ID: 15542163
[TBL] [Abstract][Full Text] [Related]
40. Effectiveness of brachytherapy and fractionated stereotactic radiotherapy boost for persistent nasopharyngeal carcinoma.
Yau TK; Sze WM; Lee WM; Yeung MW; Leung KC; Hung WM; Chan WI
Head Neck; 2004 Dec; 26(12):1024-30. PubMed ID: 15390194
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
